TD Asset Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-53,266
Closed -$1.02M 1274
2025
Q2
$1.02M Sell
53,266
-1
-0% -$16 ﹤0.01% 1055
2025
Q1
$589K Buy
+53,267
New +$635K ﹤0.01% 1129
2024
Q1
Sell
-6,176
Closed -$501K 1423
2023
Q4
$501K Hold
6,176
﹤0.01% 1299
2023
Q3
$1.01M Hold
6,176
﹤0.01% 1139
2023
Q2
$2.03M Hold
6,176
﹤0.01% 965
2023
Q1
$1.7M Sell
6,176
-185
-3% -$67.9K ﹤0.01% 1021
2022
Q4
$2.46M Buy
6,361
+938
+17% +$265K ﹤0.01% 925
2022
Q3
$1.34M Buy
5,423
+502
+10% +$134K ﹤0.01% 1111
2022
Q2
$1.1M Sell
4,921
-1,608
-25% -$692K ﹤0.01% 1170
2022
Q1
$4.45M Buy
6,529
+411
+7% +$247K ﹤0.01% 848
2021
Q4
$4.23M Buy
6,118
+775
+15% +$573K ﹤0.01% 912
2021
Q3
$3.96M Buy
5,343
+207
+4% +$141K ﹤0.01% 881
2021
Q2
$3.16M Sell
5,136
-2,560
-33% -$1.96M ﹤0.01% 951
2021
Q1
$6.28M Buy
7,696
+5,888
+326% +$4.54M 0.01% 764
2020
Q4
$1.54M Buy
1,808
+687
+61% +$529K ﹤0.01% 1093
2020
Q3
$841K Buy
+1,121
New +$921K ﹤0.01% 1117

Other funds holding OM

TD Asset Management's OM Position: Q3 2025 in Review

TD Asset Management sold out of Outset Medical (OM) in Q3 2025, closing a stake of 53,266 shares — an estimated $1.02M sold.

TD Asset Management first reported a position in OM in Q3 2020 and held it in 16 quarters. The position peaked at $6.28M in Q1 2021. 101 funds tracked by Wall St. Rank hold OM as of Q3 2025.

  • TD Asset Management reported no remaining Outset Medical position as of Q3 2025 after selling out during the quarter.
  • TD Asset Management sold 53,266 Outset Medical shares in Q3 2025, an estimated $1.02M.
  • TD Asset Management first reported a position in Outset Medical in Q3 2020 and held it in 16 quarters.
  • TD Asset Management's Outset Medical position peaked at $6.28M in Q1 2021.
  • 101 funds tracked by Wall St. Rank held Outset Medical as of Q3 2025.

Based on TD Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.